Cleared Traditional

Capture-CMV

K183571 · Immucor, Inc. · Microbiology
Feb 2019
Decision
45d
Days
Class 2
Risk

About This 510(k) Submission

K183571 is an FDA 510(k) clearance for the Capture-CMV, a Antigen, Iha, Cytomegalovirus (Class II — Special Controls, product code LJO), submitted by Immucor, Inc. (Norcross, US). The FDA issued a Cleared decision on February 4, 2019, 45 days after receiving the submission on December 21, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.

Submission Details

510(k) Number K183571 FDA.gov
FDA Decision Cleared SESE
Date Received December 21, 2018
Decision Date February 04, 2019
Days to Decision 45 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LJO — Antigen, Iha, Cytomegalovirus
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3175

Similar Devices — LJO Antigen, Iha, Cytomegalovirus

All 11
Capture-CMV
K203612 · Immucor, Inc. · Mar 2021
DIAMEDIX IS-CMV IGM CAPTURE TEST SYSTEM
K001767 · Diamedix Corp. · Aug 2000
HYBRID CAPTURE SYSTEM CMV DNA ASSAY
K974901 · Digene Corp. · Sep 1998
CMVGEN
K974456 · Instrumentation Laboratory CO · May 1998
ALLIANCE CYTOMEGALOVIRUS IMMEDIATE EARLY ANTIGEN DIRECT IMMUNOFLUORESCENCE ASSAY
K951851 · E.I. Dupont DE Nemours & Co., Inc. · Jul 1996
COPALIS CMV TOTAL ANTIBODY ASSAY
K955799 · Sienna Biotech, Inc. · Jul 1996